Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05092282 · ClinicalTrials.gov registry record

HITT for the Identification of Mild Traumatic Brain Injury

A clinical trial of Brain Injuries, Traumatic, sponsored by Rebiscan.

Active
Registry status
200
Enrollment target
1
Study location

NCT05092282 is a study of Brain Injuries, Traumatic that is active but no longer recruiting, run by Rebiscan. The registered enrollment target is 200 participants, below the 247-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (19% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05092282, a study of Brain Injuries, Traumatic, is active but no longer recruiting, sponsored by Rebiscan.

ACTIVE NOT RECRUITING
Registry status
200 participants
Enrollment target
1
Study location

Study Summary

Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 100 TBI patients and 100 controls.

Conditions Studied

Brain Injuries, Traumatic

Interventions

  • DEVICE Head and Intraocular Trauma Tool
  • DIAGNOSTIC_TEST SCAT-5

Study Locations (1)

Pennsylvania

  • Penn Presbyterian Medical Center - Philadelphia

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2021-08-01
Est. Completion 2026-12-31

Sponsor

Rebiscan

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05092282

The ClinicalTrials.gov registry entry for NCT05092282 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 247-participant average among 21 other Brain Injuries, Traumatic trials with a reported enrollment target (19% lower). The listed sponsor is Rebiscan, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Injuries, Traumatic appearing as the primary indexed condition, and to 2 interventions - of which Head and Intraocular Trauma Tool is the first listed.

NCT05092282 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05092282 about?

NCT05092282 is a clinical study titled "HITT for the Identification of Mild Traumatic Brain Injury". Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (...

What is the current status of trial NCT05092282?

This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2021-08-01. Estimated completion is 2026-12-31.

What conditions does trial NCT05092282 study?

This clinical trial studies the following conditions: Brain Injuries, Traumatic.

What interventions are being tested in trial NCT05092282?

The interventions under investigation include: Head and Intraocular Trauma Tool (DEVICE), SCAT-5 (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05092282?

This trial is sponsored by Rebiscan, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05092282 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Brain Injuries, Traumatic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Brain Injuries, Traumatic

All registered trials for this condition

Pennsylvania

All trials with a study site in Pennsylvania

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.